- Research works
- 42 ▲ 90% vs 2013–17
- Citations
- 1.1k 25.6 per fractional work
- Top-10% rate
- 28.7% record average 16.5%
- Open access
- 59% world 28%
Not ranked overall: Selecta Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.1×. Every wedge is a field page.
Which keywords describe research at Selecta Biosciences (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Antigen Presentation, Immunity, Innate Immunity, Dendritic Cells, Tumor Antigen, Gene Therapy and Autoimmunity.
- Lipid Metabolism
- Cancer Progression
- Angiogenesis
- Gene Expression
- Genome Engineering
- siRNA Delivery
- Chimeric Antigen Receptor
- Targeted Therapy
- Therapeutic Antibodies
- Antibody Engineering
- Viral Vectors
- AAV
- Immunotherapy
- Natural Killer Cells
- Foxp3
- Inflammation
- Tumor Antigen
- Innate Immunity
- Antigen Presentation
- Cancer Immunotherapy
- Immunity
- Dendritic Cells
- Gene Therapy
- Autoimmunity
- NK Cell Recognition
- TGF-ß
- Cancer Therapy
- Glycosylation
- Monoclonal Antibodies
- Fc Receptors
- Tumor Microenvironment
- CAR T Cells
- RNA Interference
- Cancer
- RNA-Guided
- Metabolic Syndrome
- Epidemiology
- Fatty Acid Synthase
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 38 words, with their numbers
- Cancer Immunotherapy6▲ 98×2 topics
- Antigen Presentation5▲ 113×2 topics
- Immunity5▲ 32×2 topics
- Innate Immunity4▲ 30×2 topics
- Dendritic Cells4▲ 88×1 topic
- Tumor Antigen4▲ 124×1 topic
- Gene Therapy4▲ 36×5 topics
- Inflammation3▲ 2.7×11 topics
- Autoimmunity3▲ 30×2 topics
- Foxp32▲ 78×1 topic
- NK Cell Recognition2▲ 57×1 topic
- Natural Killer Cells2▲ 57×1 topic
- TGF-ß2▲ 34×1 topic
- Immunotherapy2▲ 8.6×4 topics
- Cancer Therapy2▲ 8.3×4 topics
- AAV2▲ 76×1 topic
- Glycosylation2▲ 22×2 topics
- Viral Vectors2▲ 76×1 topic
- Monoclonal Antibodies2▲ 31×3 topics
- Antibody Engineering2▲ 40×1 topic
- Fc Receptors2▲ 40×1 topic
- Therapeutic Antibodies2▲ 32×2 topics
- Tumor Microenvironment2▲ 11×4 topics
- Targeted Therapy2▲ 17×4 topics
- CAR T Cells2▲ 83×1 topic
- Chimeric Antigen Receptor2▲ 83×1 topic
- RNA Interference2▲ 31×1 topic
- siRNA Delivery2▲ 46×1 topic
- Cancer1▲ 2.4×5 topics
- Genome Engineering1▲ 54×1 topic
- RNA-Guided1▲ 54×1 topic
- Gene Expression1▲ 4.8×3 topics
- Metabolic Syndrome1▲ 3.4×2 topics
- Angiogenesis1▲ 6.1×3 topics
- Epidemiology1▼ 0.62×9 topics
- Cancer Progression1▲ 10×2 topics
- Fatty Acid Synthase1▲ 60×1 topic
- Lipid Metabolism1▲ 60×1 topic
Which research topics does Selecta Biosciences (United States) publish most on?
By volume in 2022–2025: Virus-based gene therapy research, CAR-T cell therapy research, CRISPR and Genetic Engineering and Cancer, Lipids, and Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Virus-based gene therapy research Genetics 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 CRISPR and Genetic Engineering Molecular Biology 1 works
- 4 Cancer, Lipids, and Metabolism Cancer Research 1 works
- 5 Peptidase Inhibition and Analysis Oncology 1 works
- 6 Signaling Pathways in Disease Molecular Biology 1 works
- 7 RNA Interference and Gene Delivery Molecular Biology 1 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 9 Cancer Genomics and Diagnostics Cancer Research 1 works
- 10 Hematopoietic Stem Cell Transplantation Hematology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Selecta Biosciences (United States)'s research output changed?
Output in 2018–2022 was 90% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Watertown
- Boston Biomedical Research Institute
- Primary Source
- Cambridge Scientific (United States)
- Radiation Monitoring Devices (United States)
- Arsenal Medical (United States)
- Pathfinder International
- New England Research Institutes
- Perkins School for Blind
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.